Interleukin Genetics Nearly Doubles Revenues in Q4 | GenomeWeb

NEW YORK (GenomeWeb News) — Interleukin Genetics said after the close of market Thursday that its fourth quarter revenues nearly doubled year over year on increased royalty income and genetic testing revenue through the Amway Global sales channel.

Revenues for the three months ended Dec. 31, 2013, were $671,000 compared to $339,000 in the year-ago period. Genetic testing service revenue totaled $424,000 in the quarter, up from $317,000 in Q4 2012, while other revenues jumped to $247,000 from $22,000 in the prior-year period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.